Curtiss-Wright (CW) director receives 981 deferred shares under 2024 plan

Rhea-AI Filing Summary

Curtiss-Wright Corporation director stock award and deferral

A director of Curtiss-Wright Corporation acquired 981 shares of common stock on 01/02/2026, reported as an acquisition transaction. Following this award, the director beneficially owns 5,988 shares directly.

The shares were issued under the company’s 2024 Omnibus Incentive Plan, which allows non-employee directors to defer compensation, including annual restricted stock awards and cash retainers, into stock to be received at a later date. The 981 shares relate to compensation earned in 2022 but deferred until January 2, 2026, with the number of shares determined by dividing the award value by the New York Stock Exchange closing price on the Board’s original approval date and rounded up to the nearest whole share, including related dividend credits. The reported price reference is the $572.38 NYSE closing price as of January 2, 2026.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Wallace Peter C

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	981	$572.38	$562K

Holdings After Transaction: Common Stock — 5,988 shares (Direct)

Footnotes (1)

1. Shares were acquired through the Corporation's 2024 Omnibus Incentive Plan whereby non-employee directors may elect to defer their compensation, including their annual restricted stock award, and/or receive their annual retainer and meeting fees in the form of stock to a later date. This amount reflects shares that were earned in 2022, but receipt was deferred to January 2, 2026. Share total represents the annual restricted stock award to be received in stock in that year. The number of shares acquired for the annual restricted stock award is calculated based on the value of the award divided by the closing price for the Issuer's common stock as reported by the New York Stock Exchange on the date the Board initially approved the award. The number of shares is rounded up to the nearest whole share and included dividend credits earned on outstanding awards. Price is based on the closing market price for the Issuer's securities on the New York Stock Exchange as of January 2, 2026. The date recipient elected to receive his shares.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wallace Peter C

(Last) (First) (Middle)

C/O CURTISS-WRIGHT CORPORATION

130 HARBOUR PLACE DRIVE

(Street)

DAVIDSON NC 28036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CURTISS WRIGHT CORP [ CW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/02/2026		A(1)		981(2)	A	$572.38(3)	5,988	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares were acquired through the Corporation's 2024 Omnibus Incentive Plan whereby non-employee directors may elect to defer their compensation, including their annual restricted stock award, and/or receive their annual retainer and meeting fees in the form of stock to a later date.

2. This amount reflects shares that were earned in 2022, but receipt was deferred to January 2, 2026. Share total represents the annual restricted stock award to be received in stock in that year. The number of shares acquired for the annual restricted stock award is calculated based on the value of the award divided by the closing price for the Issuer's common stock as reported by the New York Stock Exchange on the date the Board initially approved the award. The number of shares is rounded up to the nearest whole share and included dividend credits earned on outstanding awards.

3. Price is based on the closing market price for the Issuer's securities on the New York Stock Exchange as of January 2, 2026. The date recipient elected to receive his shares.

Remarks:

	George P. McDonald by Power of Attorney for Peter C. Wallace	01/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction was reported for CW in this filing?

The filing reports that a director of Curtiss-Wright Corporation (CW) acquired 981 shares of common stock on 01/02/2026, classified as an acquisition transaction.

How many Curtiss-Wright (CW) shares does the director own after this transaction?

After the reported transaction, the director beneficially owns 5,988 shares of Curtiss-Wright Corporation common stock in direct ownership.

What plan was used for the director’s stock acquisition at Curtiss-Wright (CW)?

The shares were acquired through the company’s 2024 Omnibus Incentive Plan, which permits non-employee directors to defer compensation and receive it later in the form of stock, including annual restricted stock awards and retainers.

When were the Curtiss-Wright (CW) director’s shares originally earned and when received?

The 981 shares reported were earned in 2022, but the director deferred receipt until January 2, 2026, when the shares were delivered.

How was the number of Curtiss-Wright (CW) shares for the director’s award calculated?

The share count for the annual restricted stock award was calculated by dividing the award’s value by the NYSE closing price of Curtiss-Wright common stock on the date the Board initially approved the award, then rounding up to the nearest whole share and adding dividend credits.

What price is referenced for the Curtiss-Wright (CW) director’s stock receipt?

The filing notes a price of $572.38, based on the New York Stock Exchange closing market price for Curtiss-Wright securities as of January 2, 2026, the date the director elected to receive the deferred shares.